10x Genomics jumps after forecasting Q4 revenue above estimates

10x Genomics

07/11/2025 10:55

** Shares of life sciences tech firm 10x Genomics TXG.O rise 11.6% to $14.51 premarket

** 10x Genomics expects Q4 revenue to be in the range of $154 million to $158 million, compared with analysts' estimate of $154.1 million - LSEG data

** Company posts Q3 revenue of $149 million, above estimate of $142.5 million

** As of last close, stock down 9.5% YTD

 (Reporting by Siddhi Mahatole)

 ((siddhi.mahatole@thomsonreuters.com))